Oral Decitabine Plus Cedazuridine and Venetoclax in Patients with Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukaemia: a Single-Centre, Phase 1/2 Study.Alex Bataller,Guillermo Montalban-Bravo,Alexandre Bazinet,Yesid Alvarado,Kelly Chien,Sangeetha Venugopal,Jo Ishizawa,Danielle Hammond,Mahesh Swaminathan,Koji Sasaki,Ghayas C. Issa,Nicholas J. Short,Lucia Masarova,Naval G. Daver,Tapan M. Kadia,Simona Colla,Wei Qiao,Xuelin Huang,Rashmi Kanagal-Shamanna,Stephany Hendrickson,Farhad Ravandi,Elias Jabbour,Hagop Kantarjian,Guillermo Garcia-ManeroThe Lancet Haematology（2024）引用 0|浏览52暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
